Home
Jonathan Zalevsky, Chief R&D Officer: Nektar Therapeutics NKTR Sell · Filed 05/21
Trade details
- Type
- Insider sale
- Amount
- $13,036.49
- Shares · price
- 199 sh · $65.51 a share
- Held after
- 20,975 sh
- Trade date
- 26/05/19
- Filed
- 26/05/21
- Days to filing
- 2 days
Sold 0.9% of holdings
- Share of holding sold
- 0.9%
Nektar Therapeutics trades, last 26 weeks
What else happened in Nektar Therapeutics around then
Filed or reported within 30 days of the trade day · 04/19~06/18Jonathan Zalevsky's recent trades
- Jonathan Zalevsky
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$13.4K
186 sh
$13.4K
Filed 08/18
Traded 08/18
- Jonathan Zalevsky
Planned sale10b5-1 planNektar Therapeutics
Planned sale10b5-1 planNektar Therapeutics
NKTR
$371.5K
5,681 sh
$371.5K
Filed 06/30
Traded 06/30
- Jonathan Zalevsky
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$336.2K
5,538 sh
$336.2K
Filed 06/17
Traded 06/15
- Jonathan Zalevsky
Planned sale10b5-1 planNektar Therapeutics
Planned sale10b5-1 planNektar Therapeutics
NKTR
$328.8K
5,538 sh
$328.8K
Filed 06/15
Traded 06/15
- Jonathan Zalevsky
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$13K
199 sh
$13K
Filed 05/19
Traded 05/19